“Sapheon will significantly enhance Covidien’s global peripheral vascular business by providing additional treatment options for physicians and their patients who suffer from [chronic venous insufficiency],” said Brian Verrier, president of peripheral vascular businesses of Covidien, in a news release.
Financial terms of the acquisition were not disclosed.
More articles on acquisitions:
Premier to acquire Aperek for $48.5M
5 recent device, biotech company acquisitions
What Cerner’s acquisition of Siemens Health Services will mean for the health IT market
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
